指南与共识银屑病与炎症性皮肤病

泛发性脓疱型银屑病:关于临床病程、诊断、治疗目标与疾病管理的全球德尔菲共识

Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2023-02-04

该德尔菲共识通过系统文献综述制定声明,由皮肤科专家组经两轮在线问卷评分,共识阈值为≥80%同意。21名专家在临床病程与发作定义、诊断、治疗目标、整体管理四个领域分别对70.9%、61.8%、100.0%、81.8%的声明达成共识,并据此提出GPP管理算法。

要点

  • GPP在表型、遗传和免疫上不同于斑块状银屑病,专家达成明确共识。
  • 所有急性和长期治疗目标均达成共识,包括快速持续清除脓疱、红斑、鳞屑和结痂。
  • 潜在诱因、相关共病和鉴别诊断的共识率低,需要进一步证据。

核心结论

  • 全球皮肤科专家就GPP治疗的有临床意义目标、GPP发作的关键特征以及评估疾病严重程度和多学科管理的方法达成共识。
  • 在此基础之上,作者提出了供临床实践使用的GPP患者管理算法。

研究设计与样本

  • 采用系统文献综述确定已发表文献并制定声明,声明分为临床病程与发作定义、诊断、治疗目标、整体管理四个关键领域。
  • 由皮肤科专家组通过两轮在线问卷以李克特量表对声明进行评分,共识阈值为≥80%同意。
  • 共有21名专家组成员参与。

主要发现

  • 21名专家组成员在「临床病程与发作定义」「诊断」「治疗目标」「整体管理」领域分别对70.9%、61.8%、100.0%、81.8%的声明达成共识。
  • GPP在表型、遗传和免疫上不同于斑块状银屑病,对此有明确共识。
  • 临床病程高度可变,并发症范围广泛。
  • 支持GPP诊断的临床和组织学特征获得高度一致;实验室评估被认为有助于诊断和监测疾病严重程度,但个别检测的价值存在不确定性。
  • 所有急性和长期治疗目标均达成共识,包括快速持续清除脓疱、红斑、鳞屑和结痂,清除皮损和预防新发作。

关键数值与推荐

  • 共识阈值:专家组≥80%同意。
  • 「治疗目标」领域声明共识率为100.0%。
  • 「整体管理」领域声明共识率为81.8%。
  • 「临床病程与发作定义」领域声明共识率为70.9%。
  • 「诊断」领域声明共识率为61.8%。

临床怎么用

  • 作者基于共识提出GPP患者管理算法,供临床实践使用。

局限性

  • 潜在诱因、相关共病和鉴别诊断的共识率低,表明需要进一步证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Generalized pustular psoriasis (GPP) is a rare and highly heterogeneous skin disease, characterized by flares of neutrophilic pustules and erythema. As a rare disease with few clinical studies and no standardized management approaches, there is a paucity of knowledge regarding GPP. OBJECTIVES: Conduct a Delphi panel study to identify current evidence and gain advanced insights into GPP. METHODS: A systematic literature review was used to identify published literature and develop statements categorized into four key domains: clinical course and flare definition; diagnosis; treatment goals; and holistic management. Statements were rated on a Likert scale by a panel of dermatologists in two rounds of online questionnaires; the threshold for consensus was agreement by ≥80%. RESULTS: Twenty-one panellists reached consensus on 70.9%, 61.8%, 100.0% and 81.8% of statements in the 'clinical course and flare definition', 'diagnosis', 'treatment goals' and 'holistic management of GPP' domains, respectively. There was clear consensus on GPP being phenotypically, genetically and immunologically distinct from plaque psoriasis. Clinical course is highly variable, with an extensive range of complications. Clinical and histologic features supporting GPP diagnosis reached high levels of agreement, and although laboratory evaluations were considered helpful for diagnosis and monitoring disease severity, there was uncertainty around the value of individual tests. All acute and long-term treatment goals reached consensus, including rapid and sustained clearance of pustules, erythema, scaling and crust, clearance of skin lesions and prevention of new flares. Potential triggers, associated comorbidities and differential diagnoses achieved low rates of consensus, indicating that further evidence is needed. CONCLUSIONS: Global consensus between dermatologists was reached on clinically meaningful goals for GPP treatment, on key features of GPP flares and on approaches for assessing disease severity and multidisciplinary management of patients. On this basis, we present a management algorithm for patients with GPP for use in clinical practice.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Puig L, Choon SE, Gottlieb AB, et al. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol. 2023. PMID: 36606566. doi:10.1111/jdv.18851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。